학술논문
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Document Type
Article
Author
Mosenzon, Ofri; Wiviott, Stephen D; Cahn, Avivit; Rozenberg, Aliza; Yanuv, Ilan; Goodrich, Erica L; Murphy, Sabina A; Heerspink, Hiddo J L; Zelniker, Thomas A; Dwyer, Jamie P; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Kato, Eri T; Gause-Nilsson, Ingrid A M; Fredriksson, Martin; Johansson, Peter A; Langkilde, Anna Maria; Sabatine, Marc S; Raz, Itamar
Source
In The Lancet Diabetes & Endocrinology August 2019 7(8):606-617
Subject
Language
ISSN
2213-8587